CRC-403: A phase 1/2 study of bbT369, a dual targeting CAR T-cell drug product with a gene edit, in relapsed and/or refractory B-cell non-Hodgkin lymphoma (NHL). A first-in-human phase 1 study of oral ...
ABP News on MSN
From NEET success to courtroom fight: 19-year-old aspirant wins Supreme Court relief after arguing own case
On a February afternoon inside the Supreme Court of India, just as the bench led by Chief Justice Surya Kant was preparing to rise, a young voice requested ten more minutes. The plea did not come from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results